EUVIMEDEUVIMED entdecken
Crossref

MoS 2 ‐Doped Iron Oxide Nanozyme with Co‐Catalytic Enhancement for Tumor Ferroptosis Guided by Magnetic Resonance Imaging

Xiaoxun Liu, Maosong Qiu, Qiuyi Xu, Meiju Sui, Ruifang Wang, Sha Li, Lei Zhang, Shizhen Chen iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202505441 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xiaoxun Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and …. Hauptthemen laut MEDLINE: Ferroptosis, Magnetic Resonance Imaging, Molybdenum, Ferric Compounds. Die Arbeit nennt 38 Literaturangaben. Gefördert von: CAS Youth Interdisciplinary Team, Postdoctoral Research Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fe 3 O 4 nanoparticles exhibit therapeutic and diagnostic capabilities by inducing ferroptosis through reactive oxygen species generated by the Fenton reaction and enhancing magnetic resonance imaging (MRI) contrast. However, the efficacy of ferroptosis induced by Fe 3 O 4 is limited by several factors, including low Fe 2+ concentration, restricted Fenton‐active sites, excessive glutathione (GSH), and insufficient acidity of tumor cells. In this study, MoS 2 ‐doped Fe 3 O 4 , with peroxidase and glutathione oxidase‐like activities, was functionalized with tamoxifen (TAM) and coated with bovine serum albumin (BSA) to construct Fe 3 O 4 /MoS 2 @TAM/BSA (FMTB) nanoparticles. The incorporation of MoS 2 facilitated the generation of abundant oxygen vacancies, which increased the number of active sites, acted as a co‐catalyst to accelerate the reduction of Fe 3+ to Fe 2+ , and promoted GSH consumption, resulting in a 51.3% increase in Fenton activity and a 4.3‐fold enhancement in GSH consumption compared to Fe 3 O 4 alone. The released TAM inhibited mitochondrial complex I and improved tumor cellular acidity, thereby creating a conducive environment for the Fenton reaction. By enhancing peroxidase‐like activity through co‐catalysis and reducing cellular pH, FMTB achieved a 70.6% tumor growth inhibition, in contrast to the 20.8% inhibition observed with Fe 3 O 4 alone. Furthermore, the FMTB‐mediated tumor T 2 ‐weighted MRI signal was attenuated by 17% compared to that of Fe 3 O 4 . Thus, this multienzyme‐based platform presents a novel strategy for highly efficient ferroptosis therapy against tumors by enhancing Fenton reaction efficiency and depleting GSH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMagnetic Resonance ImagingMolybdenumFerric CompoundsDisulfidesNeoplasmsAnimalsHumansCatalysisCell Line, TumorMiceGlutathione

Stichwörter der Autor:innen

Fe3O4Fenton reactionFerroptosisMagnetic resonance imagingNanozyme

Substanzen

MolybdenumFerric CompoundsGlutathioneferric oxideDisulfides

Autor:innen und Institutionen

  • State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and…
  • University of Chinese Academy of Sciences, Beijing, P. R. China.

ORCID-Profile: Shizhen Chen

Förderung

  • CAS Youth Interdisciplinary Team
  • Postdoctoral Research Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Liu, X., Qiu, M., Xu, Q., Sui, M., Wang, R., Li, S., Zhang, L., & Chen, S. (2026). MoS 2 ‐Doped Iron Oxide Nanozyme with Co‐Catalytic Enhancement for Tumor Ferroptosis Guided by Magnetic Resonance Imaging. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505441

Vancouver

Liu X, Qiu M, Xu Q, Sui M, Wang R, Li S, et al. MoS 2 ‐Doped Iron Oxide Nanozyme with Co‐Catalytic Enhancement for Tumor Ferroptosis Guided by Magnetic Resonance Imaging. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505441

BibTeX
@article{Liu2026,
  author = {Liu, Xiaoxun and Qiu, Maosong and Xu, Qiuyi and Sui, Meiju and Wang, Ruifang and Li, Sha and Zhang, Lei and Chen, Shizhen},
  title = {MoS 2 ‐Doped Iron Oxide Nanozyme with Co‐Catalytic Enhancement for Tumor Ferroptosis Guided by Magnetic Resonance Imaging},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202505441}
}
Kostenlos starten →